<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05067829</url>
  </required_header>
  <id_info>
    <org_study_id>E1-21-1849</org_study_id>
    <nct_id>NCT05067829</nct_id>
  </id_info>
  <brief_title>RSI With Rocuronium in Elderly Patients</brief_title>
  <official_title>Comparison of the Effect of Rocuronium Dosing Based on Ideal, Corrected or Total Body Weight on RSI With Priming on Neuromuscular Blockage and Intubation Condition in Elderly Patients.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ankara City Hospital Bilkent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ankara City Hospital Bilkent</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      With the prolongation of life expectancy, the frequency of surgical intervention and&#xD;
      anesthesia increases in elderly patients. The RSI technique is preferred in patients with&#xD;
      aspiration risk and who will undergo general anesthesia, especially in the pandemic period,&#xD;
      to reduce or eliminate the aerosolization of respiratory secretions. The use of rocuronium at&#xD;
      a dose of 1 mg/kg in RSI also causes prolongation of the recovery of neuromuscular block.&#xD;
      This study aimed to compare the intubation conditions and TOFC 1-2 times of the rocuronium&#xD;
      doses with priming according to IBW, CBW, and TBW in RSI of patients aged &gt;65 years.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The number of elderly patients (&gt;65 y) increases, and a large proportion of these patients&#xD;
      will require surgery and anesthesia at some point. Changes in the neuromuscular junction,&#xD;
      organ systems, and cardiac output that occur with aging cause changes in response to&#xD;
      neuromuscular blockers. One of the reasons for RSI preference is to reduce or eliminate&#xD;
      aerosolization of respiratory secretions during general anesthesia and airway manipulation in&#xD;
      surgical cases during the pandemic period. Guidelines regarding this subject recommend&#xD;
      securing the airway quickly with RSI (Rapid Sequence Intubation), and it is reported that&#xD;
      aerosol production would decrease with this method. This study aimed to compare the&#xD;
      intubation conditions and the TOFC 1 and 2 response times of the patients aged 65 and above,&#xD;
      who were administered rocuronium at a priming dose (0.06 mg/kg) according to IBW, CBW, and&#xD;
      TBW before induction, followed by administration of 0.94 mg/kg rocuronium 3 minutes after the&#xD;
      anesthesia induction and intubated 45 seconds later.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 1, 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Prospective randomized contrrolled study</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The percent of excellent intubation condition</measure>
    <time_frame>During intubation from start to finish of the study</time_frame>
    <description>Score 1: Poor jaw relaxation/ Active resistance to blade/closing vokal kord/ Severe coughing or bucking/ Vigorous limb movement Score 2: Acceptable jaw relaxation/ Intermediate vokal cord moving/ slight limb and diaphram movement score 3: relaxed laryngoscopy/ abducted vocal cords/ no limb and diphragm movement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>TOF value during intubation procedure</measure>
    <time_frame>During intubation from start to finish of the study</time_frame>
    <description>Train of four monitoring during induction and intubation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to TOFR equal to zero</measure>
    <time_frame>During intubation from start to finish of the study</time_frame>
    <description>Time from rocuronium induction to TOFR equal to zero</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time to TOFC equal to 1</measure>
    <time_frame>During intubation from start to finish of the study</time_frame>
    <description>Time from rocuronium induction to TOFc equal to 1</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Rapid Sequence Induction</condition>
  <condition>Rapid Sequence Intubation</condition>
  <condition>Rocuronium</condition>
  <arm_group>
    <arm_group_label>Ideal Body weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ROCURONIUM PRIMING DOSE 0,06 MG/KG FOR IDEAL BODY WEIGHT BEFORE 3 MINUTES BEFORE INDUCTION.AFTER INDUCTION, ROCURONIUM 0,94 MG/KG FOR IDEAL BODY WEIGHT WILL BE GIVEN. INTUBATION WILL BE DONE AT 45.SECONDS.LATER ON, INTUBATION CONDITIONS, TOF VALUE DURING INTUBATION PROCEDURE,TIME OF TOF ZERO,TIME OF TOF C 1 WILL BE EVALUATED.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Total Body Weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ROCURONIUM PRIMING DOSE 0,06 MG/KG FOR TOTAL BODY WEIGHT BEFORE 3 MINUTES BEFORE INDUCTION.AFTER INDUCTION, ROCURONIUM 0,94 MG/KG FOR TOTAL BODY WEIGHT WILL BE GIVEN. INTUBATION WILL BE DONE AT 45.SECONDS.LATER ON, INTUBATION CONDITIONS, TOF VALUE DURING INTUBATION PROCEDURE,TIME OF TOF ZERO,TIME OF TOF C 1 WILL BE EVALUATED.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corrected Body Weight</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>ROCURONIUM PRIMING DOSE 0,06 MG/KG FOR CORRECTED BODY WEIGHT BEFORE 3 MINUTES BEFORE INDUCTION.AFTER INDUCTION, ROCURONIUM 0,94 MG/KG FOR CORRECTED BODY WEIGHT WILL BE GIVEN. INTUBATION WILL BE DONE AT 45.SECONDS.LATER ON, INTUBATION CONDITIONS,TOF VALUE DURING INTUBATION PROCEDURE,TIME OF TOF ZERO,TIME OF TOF C 1 WILL BE EVALUATED.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>TOF</intervention_name>
    <description>TOF monitoring after anesthesia induction</description>
    <arm_group_label>Corrected Body Weight</arm_group_label>
    <arm_group_label>Ideal Body weight</arm_group_label>
    <arm_group_label>Total Body Weight</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Elective abdominal surgery&#xD;
&#xD;
          -  Age &gt; 65 years&#xD;
&#xD;
          -  ASA I-II -III&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient with history of allergy to rocuronium&#xD;
&#xD;
          -  Body Mass Index &gt; 35 kg/m2&#xD;
&#xD;
          -  Patient who had history of difficult intubation or high possibility of difficult&#xD;
             intubation&#xD;
&#xD;
          -  Neuromuscular disease&#xD;
&#xD;
          -  Kidney failure (GFR &lt; 30 ml/dk/m2)&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nadide Aysun Postacı</last_name>
    <role>Principal Investigator</role>
    <affiliation>aysunposta@yahoo.com</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Nadide Aysun Postacı</last_name>
    <phone>+905323520383</phone>
    <email>aysunposta@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ankara City Hospital</name>
      <address>
        <city>Ankara</city>
        <zip>06800</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 24, 2021</study_first_submitted>
  <study_first_submitted_qc>September 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2021</study_first_posted>
  <last_update_submitted>September 24, 2021</last_update_submitted>
  <last_update_submitted_qc>September 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ankara City Hospital Bilkent</investigator_affiliation>
    <investigator_full_name>aysun postaci</investigator_full_name>
    <investigator_title>Associate Prof. Dr</investigator_title>
  </responsible_party>
  <keyword>Rapid Sequence Induction and Intubation</keyword>
  <keyword>Rapid Sequence Intubation</keyword>
  <keyword>Rocuronium</keyword>
  <keyword>Geriatrics</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

